Zdrowie i gospodarka · 29/08/2011
FDA Releases Draft Guidance for Industry on Oversight of Clinical Investigations
The Food and Drug Administration (FDA) has made available a draft guidance for industry on risk-based monitoring of clinical investigations, aiming to improve human subject protection and clinical trial data quality
Source: Federal Register — Health and Human ServicesOpen original release →